Degree of nephrotoxicity after intermediate‐ or high‐dose cisplatin‐based chemoradiotherapy in patients with locally advanced head and neck cancerC.M.L. Driessen, Carla M.L. van Herpen, Claudia C. M. van Opstal et al.|Head & Neck|2015Cited by 22
Exploring the potential of circulating tumour DNA to monitor treatment response in salivary duct carcinoma patients of the CABO-ASAP trialJetty A.M. Weijers, Carla M.L. van Herpen, Marjolijn J. L. Ligtenberg et al.|Oral Oncology|2023Cited by 4
Degree of nephrotoxicity after intermediate or high-dose cisplatin-based chemoradiotherapy (CRT) in patients with locally advanced head and neck cancer (LAHNC).C.M.L. Driessen, Carla M.L. van Herpen, Maike J.M. Uijen et al.|Journal of Clinical Oncology|2014Cited by 0